USD 0.0
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2022 | 4.31 Million USD | -1.67% |
2021 | 4.38 Million USD | 215.55% |
2020 | 1.38 Million USD | 4785.76% |
2019 | -29.64 Thousand USD | -15.57% |
2018 | -25.65 Thousand USD | -6.51% |
2017 | -24.08 Thousand USD | -16.37% |
2016 | -20.69 Thousand USD | -73.94% |
2015 | -11.89 Thousand USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | -100.0% |
2022 Q4 | 1.4 Million USD | 119.2% |
2022 Q2 | 1.15 Million USD | 31.0% |
2022 FY | 4.31 Million USD | -1.67% |
2022 Q1 | 881.88 Thousand USD | -51.03% |
2022 Q3 | 640.06 Thousand USD | -44.59% |
2021 Q1 | 1.79 Million USD | 85.72% |
2021 FY | 4.38 Million USD | 215.55% |
2021 Q4 | 1.8 Million USD | 5557.58% |
2021 Q3 | -33 Thousand USD | -104.03% |
2021 Q2 | 819 Thousand USD | -54.4% |
2020 Q1 | - USD | 0.0% |
2020 FY | 1.38 Million USD | 4785.76% |
2020 Q4 | 967 Thousand USD | 141.15% |
2020 Q3 | 401 Thousand USD | 1809.52% |
2020 Q2 | 21 Thousand USD | 0.0% |
2019 FY | -29.64 Thousand USD | -15.57% |
2018 FY | -25.65 Thousand USD | -6.51% |
2017 FY | -24.08 Thousand USD | -16.37% |
2016 FY | -20.69 Thousand USD | -73.94% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | -11.89 Thousand USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Bio Medica Corporation | -193 Thousand USD | 2333.161% |
Arrayit Corporation | 2.57 Million USD | -67.375% |
Atlantic International Corp. | -154.23 Thousand USD | 2894.455% |
Biocept, Inc. | -2.58 Million USD | 266.925% |
Bioqual, Inc. | 7.42 Million USD | 41.985% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 276 Thousand USD | -1461.594% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.936% |
HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -140.234% |
iMD Companies, Inc. | -23.63 Thousand USD | 18334.124% |
IDenta Corp. | 662.97 Thousand USD | -550.1% |
Interpace Biosciences, Inc. | 23.04 Million USD | 81.296% |
Integrative Health Technologies, Inc. | 77.57 Thousand USD | -5456.2% |
InVitro International | 635.98 Thousand USD | -577.689% |
Lumos Diagnostics Holdings Limited | 6.56 Million USD | 34.329% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 1.09 Million USD | -294.442% |
NovelStem International Corp. | 12 Thousand USD | -35816.667% |
Optigenex Inc. | -102.96 Thousand USD | 4285.848% |
PharmChem, Inc. | 3.9 Million USD | -10.389% |
Proteome Sciences plc | 2.09 Million USD | -105.568% |
Response Genetics, Inc | 3.94 Million USD | -9.335% |
Rennova Health, Inc. | 6.26 Million USD | 31.241% |
RushNet, Inc. | 1.1 Million USD | -290.181% |
ScreenPro Security Inc. | 856.57 Thousand USD | -403.167% |
Stella Diagnostics Inc. | - USD | -Infinity% |
StageZero Life Sciences Ltd. | -403.74 Thousand USD | 1167.5% |